{"id":6350,"date":"2025-02-10T11:12:24","date_gmt":"2025-02-10T11:12:24","guid":{"rendered":"https:\/\/www.angelssante.fr\/?p=6350"},"modified":"2025-09-03T13:40:23","modified_gmt":"2025-09-03T13:40:23","slug":"angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight","status":"publish","type":"post","link":"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/","title":{"rendered":"Angels Sant\u00e9 takes part in Sirius Neosight's \u20ac4.4M round of financing"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"6350\" class=\"elementor elementor-6350\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c7bb6a1 e-flex e-con-boxed e-con e-parent\" data-id=\"c7bb6a1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f50fb21 elementor-widget elementor-widget-heading\" data-id=\"f50fb21\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4 millions d\u2019euros de Sirius Neosight<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-54baaec elementor-widget elementor-widget-text-editor\" data-id=\"54baaec\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"WordSection1\"><p class=\"cvGsUA direction-ltr align-justify para-style-body\"><a class=\"app-aware-link\" href=\"https:\/\/www.linkedin.com\/company\/angelssante\/\" target=\"_self\" data-test-app-aware-link=\"\">Angels Sant\u00e9<\/a> est fier d\u2019annoncer sa participation \u00e0 la lev\u00e9e de fonds de <a class=\"app-aware-link\" href=\"https:\/\/sirius-neosight.com\/fr\/\" target=\"_self\" data-test-app-aware-link=\"\">Sirius Neosight<\/a> !<\/p><p>Angels Sant\u00e9 est heureux d&rsquo;accueillir Sirius NeoSight et son CEO Agn\u00e8s Bastid au sein de la famille Angels Sant\u00e9. <br \/>4,4 M\u20ac &#8211; Quel tour de table ! F\u00e9licitations \u00e0 Agn\u00e8s et \u00e0 toute l&rsquo;\u00e9quipe ! \ud83c\udf89<\/p><p>Nous sommes ravis d&rsquo;apporter notre contribution \u00e0 cette \u00e9tape importante et nous remercions nos membres qui ont donn\u00e9 de leur temps et de leur expertise.<\/p><p>Nous sommes impatients de voir Sirius NeoSight grandir, innover et cr\u00e9er des changements significatifs dans le domaine de l&rsquo;oncologie et de vous soutenir, autant que possible, dans ce voyage !<\/p><p>Continuons \u00e0 donner du pouvoir aux startups r\u00e9volutionnaires qui fa\u00e7onnent l&rsquo;avenir ! \ud83c\udf0d\u2728<br \/><br \/><\/p><p>\u00a0<\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-82b81b2 e-flex e-con-boxed e-con e-parent\" data-id=\"82b81b2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-62358ed elementor-widget elementor-widget-ucaddon_newsletter_iframe\" data-id=\"62358ed\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"ucaddon_newsletter_iframe.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\n<!-- start Newsletter iFrame -->\n\n<div class=\"mahii-iframe\"><iframe src=\"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/02\/2025-02-04-SIRIUS-NEOSIGHT-Communique-de-presse-FR.pdf\"><\/iframe><\/div>\n<!-- end Newsletter iFrame -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Angels Sant\u00e9 est fier d\u2019annoncer sa participation \u00e0 la lev\u00e9e de fonds de Sirius Neosight !<br \/>\nNous sommes ravis d\u2019apporter notre contribution \u00e0 cette \u00e9tape importante et nous remercions nos membres qui ont donn\u00e9 de leur temps et de leur expertise.<\/p>","protected":false},"author":2,"featured_media":6352,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-6350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-du-cote-de-nos-start-ups"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight - Angels Sante<\/title>\n<meta name=\"description\" content=\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l&#039;immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d&#039;amor\u00e7age de 4,5 millions d&#039;euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l&#039;industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight - Angels Sante\" \/>\n<meta property=\"og:description\" content=\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l&#039;immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d&#039;amor\u00e7age de 4,5 millions d&#039;euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l&#039;industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/\" \/>\n<meta property=\"og:site_name\" content=\"Angels Sante\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-10T11:12:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-03T13:40:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/02\/4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2750\" \/>\n\t<meta property=\"og:image:height\" content=\"1038\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"caroline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"caroline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/\"},\"author\":{\"name\":\"caroline\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/person\\\/a3091af4aa360ddf6b6f0f176518b26e\"},\"headline\":\"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight\",\"datePublished\":\"2025-02-10T11:12:24+00:00\",\"dateModified\":\"2025-09-03T13:40:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/\"},\"wordCount\":165,\"publisher\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/4.png\",\"articleSection\":[\"Du c\u00f4t\u00e9 de nos start-ups\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/\",\"name\":\"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight - Angels Sante\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/4.png\",\"datePublished\":\"2025-02-10T11:12:24+00:00\",\"dateModified\":\"2025-09-03T13:40:23+00:00\",\"description\":\"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/4.png\",\"contentUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/4.png\",\"width\":2750,\"height\":1038},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.angelssante.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/\",\"name\":\"Angel Sante\",\"description\":\"Premier r\u00e9seau de Business Angels en Europe d\u00e9di\u00e9 \u00e0 la sant\u00e9.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.angelssante.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#organization\",\"name\":\"Angel Sante\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/logo4-pdf.jpg\",\"contentUrl\":\"https:\\\/\\\/www.angelssante.fr\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/logo4-pdf.jpg\",\"width\":685,\"height\":290,\"caption\":\"Angel Sante\"},\"image\":{\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/angelssante\\\/?viewAsMember=true\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.angelssante.fr\\\/#\\\/schema\\\/person\\\/a3091af4aa360ddf6b6f0f176518b26e\",\"name\":\"caroline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g\",\"caption\":\"caroline\"},\"url\":\"https:\\\/\\\/www.angelssante.fr\\\/en\\\/author\\\/caroline\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight - Angels Sante","description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/","og_locale":"en_US","og_type":"article","og_title":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight - Angels Sante","og_description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","og_url":"https:\/\/www.angelssante.fr\/en\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/","og_site_name":"Angels Sante","article_publisher":"https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true","article_published_time":"2025-02-10T11:12:24+00:00","article_modified_time":"2025-09-03T13:40:23+00:00","og_image":[{"width":2750,"height":1038,"url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/02\/4.png","type":"image\/png"}],"author":"caroline","twitter_card":"summary_large_image","twitter_misc":{"Written by":"caroline","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/#article","isPartOf":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/"},"author":{"name":"caroline","@id":"https:\/\/www.angelssante.fr\/#\/schema\/person\/a3091af4aa360ddf6b6f0f176518b26e"},"headline":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight","datePublished":"2025-02-10T11:12:24+00:00","dateModified":"2025-09-03T13:40:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/"},"wordCount":165,"publisher":{"@id":"https:\/\/www.angelssante.fr\/#organization"},"image":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/#primaryimage"},"thumbnailUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/02\/4.png","articleSection":["Du c\u00f4t\u00e9 de nos start-ups"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/","url":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/","name":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight - Angels Sante","isPartOf":{"@id":"https:\/\/www.angelssante.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/#primaryimage"},"image":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/#primaryimage"},"thumbnailUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/02\/4.png","datePublished":"2025-02-10T11:12:24+00:00","dateModified":"2025-09-03T13:40:23+00:00","description":"HEPHAISTOS-Pharma, soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des immunoth\u00e9rapies denouvelle g\u00e9n\u00e9ration contre le cancer ciblant l'immunit\u00e9 inn\u00e9e pour augmenter le taux degu\u00e9rison des patients, a finalis\u00e9 son tour d'amor\u00e7age de 4,5 millions d'euros, auquel a particip\u00e9Angels Sant\u00e9, pour financer l'industrialisation et faire progresser son candidat principal ONCO-Boost vers la clinique.","breadcrumb":{"@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/#primaryimage","url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/02\/4.png","contentUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2025\/02\/4.png","width":2750,"height":1038},{"@type":"BreadcrumbList","@id":"https:\/\/www.angelssante.fr\/angels-sante-participe-a-la-levee-de-fonds-de-44me-de-sirius-neosight\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.angelssante.fr\/"},{"@type":"ListItem","position":2,"name":"Angels Sant\u00e9 participe \u00e0 la lev\u00e9e de fonds de 4,4M\u20ac de Sirius Neosight"}]},{"@type":"WebSite","@id":"https:\/\/www.angelssante.fr\/#website","url":"https:\/\/www.angelssante.fr\/","name":"Angel Sante","description":"Premier r\u00e9seau de Business Angels en Europe d\u00e9di\u00e9 \u00e0 la sant\u00e9.","publisher":{"@id":"https:\/\/www.angelssante.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.angelssante.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.angelssante.fr\/#organization","name":"Angel Sante","url":"https:\/\/www.angelssante.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.angelssante.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/02\/logo4-pdf.jpg","contentUrl":"https:\/\/www.angelssante.fr\/wp-content\/uploads\/2024\/02\/logo4-pdf.jpg","width":685,"height":290,"caption":"Angel Sante"},"image":{"@id":"https:\/\/www.angelssante.fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/angelssante\/?viewAsMember=true"]},{"@type":"Person","@id":"https:\/\/www.angelssante.fr\/#\/schema\/person\/a3091af4aa360ddf6b6f0f176518b26e","name":"caroline","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/99fada4791cc438694b17db6c935e6be622048c73401455708bb9858b4a4cd29?s=96&d=mm&r=g","caption":"caroline"},"url":"https:\/\/www.angelssante.fr\/en\/author\/caroline\/"}]}},"_links":{"self":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/6350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/comments?post=6350"}],"version-history":[{"count":7,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/6350\/revisions"}],"predecessor-version":[{"id":6359,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/posts\/6350\/revisions\/6359"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/media\/6352"}],"wp:attachment":[{"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/media?parent=6350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/categories?post=6350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.angelssante.fr\/en\/wp-json\/wp\/v2\/tags?post=6350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}